Syndax Pharmaceuticals, Inc. (SNDX)
21.00
-0.39
(-1.82%)
USD |
NASDAQ |
Apr 27, 16:00
21.05
+0.05
(+0.24%)
Pre-Market: 08:39
Syndax Pharmaceuticals Profit Margin (Quarterly) : -98.96% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -- |
| Vera Therapeutics, Inc. | -- |
| Biogen, Inc. | -2.24% |
| Johnson & Johnson | 21.75% |
| Tango Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -169.8% |
| Return on Assets | -46.90% |
| Return on Invested Capital | -55.56% |
| Gross Profit Margin (Quarterly) | 96.06% |
| Operating Margin (Quarterly) | -91.01% |
| Return on Net Operating Assets | -554.3% |